Daniel Levitt

Daniel Levitt is a seasoned pharmaceutical executive with extensive experience in research and development, clinical affairs, and corporate leadership. He has held the position of Executive Vice President and Chief Medical Officer (CMO) at Cerimon Pharmaceuticals.2

Career Highlights

Previous Roles::

• Chief Medical Officer and Head of Clinical and Regulatory Affairs at Dynavax Technologies15
• Chief Operating Officer and Head of Research and Development at Affymax5
• Executive Vice President of Research and Development at Cerimon Pharmaceuticals3

Current Positions::

• Executive Vice President and Chief Medical Officer at Cerimon Pharmaceuticals2
• Director on the Board of Sorrento Therapeutics4

Expertise and Contributions

Dr. Levitt has been instrumental in directing product development activities and managing clinical programs for various pharmaceutical companies. At Cerimon Pharmaceuticals, he has been involved in overseeing the development of the company's lead product candidate, Simulect(R).3

His expertise extends to conducting proof-of-concept studies, such as the one for basiliximab in treating noninfectious uveitis, a potentially sight-threatening inflammation of the eye.6

Industry Experience

With over two decades of experience in the biotechnology and pharmaceutical industries, Dr. Levitt has worked with several companies, providing consulting services to biotech and pharma firms since early 2009.1 His broad experience in corporate management, research and development, and clinical affairs has made him a valuable asset in the pharmaceutical industry.